ANI Pharmaceuticals, Inc.
ANIP
$75.33
-$1.20-1.57%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 94.96% | 77.11% | -9.53% | -34.86% | -31.64% |
| Total Receivables | 26.77% | 28.65% | 35.86% | 27.79% | 36.80% |
| Inventory | 4.59% | -1.06% | 10.26% | 20.71% | 23.01% |
| Prepaid Expenses | 27.89% | 6.23% | 8.09% | 46.83% | 3.30% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1,299.13% | 49.71% | -89.39% | -22.00% | -89.96% |
| Total Current Assets | 42.51% | 33.97% | 8.49% | -0.79% | 1.66% |
|
|
|||||
| Total Current Assets | 42.51% | 33.97% | 8.49% | -0.79% | 1.66% |
| Net Property, Plant & Equipment | 9.87% | 12.09% | 14.73% | 19.89% | 27.52% |
| Long-term Investments | 4.15% | 3.40% | 114.50% | 114.95% | 112.57% |
| Goodwill | 4.15% | 3.40% | 114.50% | 114.95% | 112.57% |
| Total Other Intangibles | -11.50% | -12.29% | 184.21% | 174.68% | 159.24% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -12.22% | 8.12% | 5.60% | 5.70% | -4.27% |
| Total Assets | 12.14% | 9.38% | 45.86% | 41.32% | 42.02% |
|
|
|||||
| Total Accounts Payable | 37.08% | 14.62% | 12.10% | 7.34% | 24.46% |
| Total Accrued Expenses | 55.52% | 62.14% | 109.28% | 92.38% | 60.45% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 110.37% | 113.10% | 1,454.82% | 1,216.82% | 979.06% |
| Total Finance Division Other Current Liabilities | 10.86% | 30.55% | 51.02% | 27.34% | -6.55% |
| Total Other Current Liabilities | 10.86% | 30.55% | 51.02% | 27.34% | -6.55% |
| Total Current Liabilities | 43.02% | 42.45% | 69.19% | 47.43% | 33.67% |
|
|
|||||
| Total Current Liabilities | 43.02% | 42.45% | 69.19% | 47.43% | 33.67% |
| Long-Term Debt | -2.46% | -2.13% | 113.91% | 114.90% | 115.90% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 62.30% | 43.11% | 38.87% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -73.04% | -62.78% | 166.11% | 155.32% | 181.76% |
| Total Liabilities | 5.11% | 5.34% | 100.25% | 93.95% | 91.56% |
|
|
|||||
| Common Stock & APIC | 14.70% | 14.74% | 1.77% | 1.42% | 1.08% |
| Retained Earnings | 76.97% | 43.54% | -18.20% | -36.38% | -25.14% |
| Treasury Stock & Other | -105.25% | -94.24% | -141.44% | -193.84% | -1,182.35% |
| Total Common Equity | 33.95% | 24.60% | -4.17% | -7.38% | -6.72% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 33.95% | 24.60% | -4.17% | -7.38% | -6.72% |
| Total Preferred Equity | -- | -- | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 26.18% | 17.41% | -3.95% | -6.99% | -6.35% |
|
|
|||||